Dr. William T. Tse
Claim this profileMetroHealth Medical Center
Area of expertise
Lung Cancer
William T. Tse has run 9 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
William T. Tse has run 6 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
MetroHealth Medical Center
Norton Children's Hospital
Clinical Trials William T. Tse is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting
2 awards
Phase 3
10 criteria
More about William T. Tse
Clinical Trial Related
8 years of experience running clinical trials · Led 49 trials as a Principal Investigator · 13 Active Clinical Trials
Treatments William T. Tse has experience with
- Nivolumab
- Cisplatin
- Paclitaxel
- Ipilimumab
- Atezolizumab
- Pembrolizumab
Breakdown of trials William T. Tse has run
Lung Cancer
Breast Cancer
Breast cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William T. Tse specialize in?
William T. Tse focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage II.
Is William T. Tse currently recruiting for clinical trials?
Yes, William T. Tse is currently recruiting for 13 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that William T. Tse has studied deeply?
Yes, William T. Tse has studied treatments such as Nivolumab, Cisplatin, Paclitaxel.
What is the best way to schedule an appointment with William T. Tse?
Apply for one of the trials that William T. Tse is conducting.
What is the office address of William T. Tse?
The office of William T. Tse is located at: MetroHealth Medical Center, Cleveland, Ohio 44109 United States. This is the address for their practice at the MetroHealth Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.